Serum Magnesium in Proton Pump Inhibitors Users and Non-Users
References
- Savarino E, Marabotto E, Zentilin P, Furnari M, Bodini G, Pellegatta G, Dulbecco P, Savarino V. A safety review of proton pump inhibitors to treat acid-related digestive diseases. Expert Opin Drug Saf. 2018;17(8):785–794.
https://doi.org/10.1080/14740338.2018.1497155 - Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil. 2018;24(2):182–188.
https://doi.org/10.5056/jnm18001 - Lavu A, Ansari M, Acharya R, Vilakkathala R. A cross-sectional study on single-day use of proton pump inhibitors in tertiary care hospitals of South India. Hosp Pharm. 2019;56(2):109–115.
https://doi.org/10.1177/0018578719873876 - Nakamura N, Yoneda K, Higo T, Kusumoto M. Monitoring of serum magnesium levels during long-term use of proton pump inhibitors in elderly Japanese patients: is it really necessary or not? J Pharm Health Care Sci. 2022;8:35.
https://doi.org/10.1186/s40780-022-00266-7 - William JH, Danziger J. Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms. World J Nephrol. 2016;5(2):152–161.
https://doi.org/10.5527/wjn.v5.i2.152 - Chrysant SG. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias. Expert Rev Cardiovasc Ther. 2019;17(5):345–351.
https://doi.org/10.1080/14779072.2019.1615446 - Shabajee N, Lamb EJ, Sturgess I, Sumathipala RW. Omeprazole and refractory hypomagnesaemia. BMJ. 2008;337:a425.
https://doi.org/10.1136/bmj.39505.738981.BE - Cundy T, Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf). 2008;69(2):338–341.
https://doi.org/10.1111/j.1365-2265.2008.03194.x - Mackay JD, Bladon PT. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series. QJM. 2010;103(6):387–395.
https://doi.org/10.1093/qjmed/hcq021 - Srinutta T, Chewcharat A, Takkavatakarn K, Praditpornsilpa K, Eiam-Ong S, Jaber BL, Susantitaphong P. Proton pump inhibitors and hypomagnesemia: a meta-analysis of observational studies. Medicine (Baltimore). 2019;98(44):e17788.
https://doi.org/10.1097/MD.0000000000017788 - William JH, Danziger J. Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms. World J Nephrol. 2016;5(2):152–161.
https://doi.org/10.5527/wjn.v5.i2.152 - Ryan MF, Barbour H. Magnesium measurement in routine clinical practice. Ann Clin Biochem. 1998;35(4):449–459.
https://doi.org/10.1177/000456329803500401 - Hofman A, Brusselle GG, Murad SD, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten TE, Peeters RP, Stricker BH. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol. 2015;30(8):661–708.
https://doi.org/10.1007/s10654-015-0082-x - Zahid U, Ijaz F. Uncovering the hidden risks of proton pump inhibitors: a call for caution in long-term use. Pak J Clin Res. 2024;1(1):14–17.
- Bobrowicz M, Pachucki J, Popow M. Hypomagnesaemia leading to parathyroid dysfunction, hypocalcaemia, and hypokalaemia as a complication of long-term treatment with a proton pump inhibitor—a literature review. Endokrynol Pol. 2024;75(1):1–7.
https://doi.org/10.5603/ep.98576 - Seah S, Tan YK, Teh K, Loh WJ, Tan PT, Goh LC, Toh MP, Lee CH. Proton-pump inhibitor uses amongst patients with severe hypomagnesemia. Front Pharmacol. 2023;14:1092476.
https://doi.org/10.3389/fphar.2023.1092476 - Hadi KN, Hadi NK, Bangash A, Rahim F. Association of hypomagnesemia with chronic use of proton-pump inhibitors in patients visiting a tertiary care hospital in Peshawar, Pakistan. Pak J Med Sci. 2025;41(5):1388–1394.
https://doi.org/10.12669/pjms.41.5.11993 - Siddiqi FA, Anwar W, Aziz MS, Hammad M, Arshad AR, Naseer U. Relationship between long-term proton pump inhibitor use and serum magnesium levels: a cross-sectional study. Life Sci. 2023;4:6–12.
https://doi.org/10.37185/LnS.1.1.326 - Yamashiro K, Hosomi K, Yokoyama S, Ogata F, Nakamura T, Kawasaki N. Adverse event profiles of hypomagnesemia caused by proton pump inhibitors using the Japanese Adverse Drug Event Report (JADER) database. Pharmazie. 2022;77(6):243–247.
https://doi.org/10.1038/s41598-022-22257-2 - Anwar AO, Alfarsi A, Al-Farsi AA. Hypomagnesemia-induced seizures post severe acute kidney injury. Cureus. 2022;14(5):e1–e5.
- Torres Cruz L, Pulipaka SP, Anthony N, Liu J, Barkhodarian M, Al Awwa A, Saeed H. A rare case of severe hypokalemia and hypomagnesemia due to venetoclax and polypharmacy leading to life-threatening cardiac arrhythmias. Case Rep Oncol. 2023;16(3):1390–1394.
https://doi.org/10.1159/000534135 - Ansong S, Nwosu KU, Keke V, Rajoo S, Aboagye-Kumi M, Nwosu K. Prolonged proton pump inhibitor use and electrolyte abnormalities: a case presentation and literature review. Cureus. 2025;17(2):e87795.
https://doi.org/10.7759/cureus.87795 - Slavin M, Frankenfeld CL, Guirguis AB, Seng EK. Use of acid-suppression therapy and odds of migraine and severe headache in the national health and nutrition examination survey. Neurol Clin Pract. 2024;14(5):e200302.
https://doi.org/10.1212/CPJ.0000000000200302
Language: English
Page range: 29 - 38
Submitted on: Nov 12, 2025
Accepted on: Dec 15, 2025
Published on: Mar 5, 2025
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2025 Sumana Sen, Jassica Katta, Mahender Kumar Medisetty, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.